Objectives: Adults aging with HIV are at risk for poorer neurocognitive and daily functioning. Identifying factors to protect such outcomes is a significant research priority. The aim of this study was to explore the role of resilience in cognitive and everyday functioning in a largely African American and low socioeconomic status sample of adults and older adults with HIV in the Deep South.
| INTRODUCTION
The prevalence and incidence of HIV among older adults are growing due to decreases in mortality with antiretroviral therapy and an increase in new diagnoses in this age group. Estimates suggest that by 2020 70% of those living with HIV/AIDS in the USA will be aged 50 and above. 1 Adults and older adults with HIV are at an increased risk for neurocognitive impairment (namely, HIV-associated neurocognitive disorder [HAND] ) as a combined result of the effects of both aging as well as HIV disease. 2 This neurocognitive impairment also puts this population at a higher risk for daily functioning impairments as well as poorer psychosocial and mental health outcomes. 3, 4 As such, it is crucial to identify ways to promote successful cognitive aging outcomes in this population as they reach older ages.
Positive psychological factors may be one area that may promote successful cognitive outcomes in older people living with HIV/AIDS (PLWHA). One such positive psychological factor is resilience. The American Psychological Association defines resilience as "the process of adapting well in the face of adversity, trauma, tragedy, threats, or significant sources of stress," or "bouncing back" from difficult experiences. 5 Resilience is conceptually very similar to processes such as grit, post-traumatic growth, and optimism. This definition of a process versus a stable personality trait suggests that resilience is adaptive and that people have the capacity to build and improve resilience. In aging populations, high resilience has been associated with positive outcomes, such as better mood and lower mortality risk, longevity, as well as higher self-rated successful aging, increased quality of life, and improved lifestyle behaviors. 6 Importantly, resilience can occur in diverse populations regardless of socioeconomic factors such as income, educational attainment, and race. In fact, some evidence suggests that, minorities, particularly African Americans, may exhibit greater levels of resilience that their White counterparts. 7 While research has traditionally focused on deleterious outcomes and risk factors associated with HIV, emerging research has begun to focus on both successful aging outcomes in this population as well as protective factors such as resilience.
Qualitative work in individuals aging with HIV has suggested that indeed psychological strengths such as resilience and hardiness are reported in this population despite the challenges of aging with HIV. 8, 9 Quantitative studies have shown that while resilience levels may be lower in older PLWHA compared with their HIV-negative counterparts, adults aging with HIV/AIDS can still experience resilience and successful aging in spite of the deleterious effects of the disease. 10, 11 Resilience has been shown to predict health-related quality of life in a recent large (N = 335) study of older gay and bisexual men. 12 Another recent study by Moore et al examined successful cognitive aging (operationally defined as freedom from cognitive, everyday, and emotional impairments) in older PLWHA, and found that self-reported levels of resilience did not differ between HIV-negative individuals defined as successful or unsuccessful cognitive agers, while it did between those HIV-positive persons who were defined as successful vs unsuccessful cognitive agers. 10 This suggests that resilience may be particularly protective for promoting successful aging outcomes in those with HIV. Another study showed that higher self-rated successful aging (using a 10-point scale) in older PLWHA had a stronger association with positive psychological traits such as resilience, optimism, and sense of personal mastery than duration or severity of HIV disease, 11 which is promising given that resilience may be a malleable intervention target. Resilience may reduce the negative influence of life stress on physical, emotional, and functional/global well-being in older PLWHA, 13 as has been demonstrated in normal aging. Key points 
| Participants and procedure
One hundred HIV+ individuals were recruited from a local HIV/AIDS clinic (see Table 1 for sample characteristics). A brief telephone screen determined eligibility, which included the following: aged 40+, HIV+, no conditions that may affect neurocognitive functioning (eg, Schizophrenia, Alzheimer's disease), not blind or deaf, no head injury with loss of consciousness longer than 30 minutes, and not currently undergoing chemo or radiation therapy. While age 50 is often used as the cutoff in studies pertaining to aging-related issues in PLWH, the current study employed a 40+ cutoff for several reasons: (1) the prevalence of HAND is higher is middle-aged and older PLWH than their younger counterparts, (2) using a younger cutoff allowed more variability in age to examine in analyses, and (3) The Connor-Davidson Resilience Scale-10 was used to measure resilience in the current study. 25 This 10-item measure contains items such as "I can deal with whatever comes my way", and responses are on a Likert scale ranging from 1 (not true at all) to 5 (true nearly all of the time). Items are summed for a total score, with higher scores reflecting greater levels of resilience. The internal consistency in the current study was high (Cronbach's α= 0.90).
| Neurocognitive functioning
Participants completed a comprehensive neurocognitive battery commonly used in the HIV literature. 3 Test scores were corrected for age, education, gender, and race/ethnicity when available and then used to calculate global and domain T-scores (verbal fluency, executive function, speed of information processing, learning, recall, working memory, motor). In order to derive neurocognitive impairment, global T-scores were transformed into clinical ratings using a validated algorithm consistent with the current nosology for HAND diagnoses for research purposes. 26 Clinical ratings of five or greater were used to define neurocognitive impairment. T-scores and neurocognitive impairment were both examined in analyses.
| Everyday functioning
Everyday functioning was assessed via two self-report questionnaires commonly used in HIV. often do your thoughts seem confused or illogical?"]). 30 Responses are on a Likert scale (Almost always, Very often, Fairly often, Once in a while, Very infrequently, and Almost never) and items reported as Fairly Often or greater were defined as "significant" cognitive symptoms. Thus, the total score for the PAOFI reflects the number of significant everyday cognitive symptoms (possible range: 0-34).
| Covariates
We considered the following covariates: age, sex/gender, race/ethnicity, education level, and income, all gathered via a demographic questionnaire. HIV characteristics were derived from clinic records and included current and nadir CD4 count as well as plasma viral load.
We also examined depressive symptoms as measured by the Center and cognitive symptoms (ie, PAOFI total scores; rho = −0.27, P < 0.01).
In a multiple regression model predicting global neurocognitive impairment, higher resilience remained significantly associated with less impairment (P = 0.03) after adjusting for variables associated with resilience and neurocognitive impairment (WRAT, income, and depressive symptoms) ( Table 2) . Similarly, when IADL dependence was the outcome, with the aforementioned covariates plus global neurocognitive impairment, resilience remained significant (P = 0.02) and was the only significant predictor in the model (Table 2) .
Given this prior analysis and the correlations between resilience and functional outcomes (IADL and PAOFI), we were interested in formally testing whether the association between neurocognitive functioning and everyday functioning traditionally reported in the literature would be mediated by resilience. First, we determined whether cognitive symptoms or IADL declines were associated with neurocognitive functioning (global T-scores) and found that greater IADL declines were associated with lower global T-scores (P = 0.04).
Cognitive symptoms were unassociated with global T-scores (P = 0.44). Then, given the association between neurocognitive functioning and IADL declines, we conducted a mediation analysis using the Barron and Kenny 34 approach to test whether the association between global neurocognitive performance and IADL declines would be mediated by resilience. As previously reported, for
Step 1, global T-scores were inversely associated with IADL declines 
| DISCUSSION
As hypothesized, resilience was related to neurocognitive performance, and more specifically neurocognitive impairment, among adults and older adults living with HIV. This effect remained after considering confounders, including demographics, cognitive reserve, and depressive symptoms. Similarly, resilience was significantly related to everyday functioning impairment, above and beyond global neurocognitive impairment. In fact, the relationship between worse cognitive functioning and greater IADL declines was weakened when associations between these factors and resilience were taken into account.
These data provide cross-sectional evidence that declines in neurocognition may lead to lower resilience, which in turn may lead to worse daily functioning. Alternatively, it may be that those who are more resilient are better able to compensate for cognitive declines and are thus less affected by these declines on everyday functioning.
This point is very significant in HIV, as numerous studies have highlighted the importance of cognitive functioning in predicting daily functioning in this population. 3 However, research has also shown cognitive deficits are not necessarily the strongest predictor of functional declines among the HIV population, but that functional ability is related to a myriad of factors (ie, depressed mood, 3, 35 substance use, 36 and apathy 37 ) in addition to cognition. While we did find that those with more depressive symptoms had lower levels of resilience, in our models predicting both global cognitive impairment and IADL dependence, resilience was still significant even when taking into account depression. This highlights the strong and independent effect of resilience on cognitive and everyday outcomes.
Perhaps, resilience may buffer some of the deleterious effects of depression on such outcomes. 
